[1] SATOH K, MAKIMURA K, HASUMI Y, et al. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital[J]. Microbiol Immunol, 2009,53(1):41-44.
[2] LEE W G, SHIN J H, UH Y, et al. First three reported cases of nosocomial fungemia caused by Candida auris[J]. J Clin Microbiol, 2011,49(9):3139-3142.
[3] BOLUKBASI Y, ERKOSE G G, ORHUN G, et al. First case of COVID-19 positive Candida auris fungemia in Turkey[J]. Mikrobiyol Bul, 2021,55(4):648-655.
[4] MOIN S, FAROOQI J, RATTANI S, et al. C. auris and non-C. auris candidemia in hospitalized adult and pediatric COVID-19 patients; single center data from Pakistan[J]. Med Mycol, 2021,59(12):1238-1242.
[5] HINRICHS C, WIESE-POSSELT M, GRAF B, et al. Successful control of Candida auris transmission in a German COVID-19 intensive care unit[J]. Mycoses, 2022,65(6):643-649.
[6] Magnasco L, Mikulska M, Giacobbe D R, et al. Spread ofcarbapenem-resistant gram-negatives and Candida auris during the COVID-19 pandemic in critically Ill patients: One step back in antimicrobial stewardship[J]. Microorganisms, 2021,9(1):95.
[7] SENOK A, ALFARESI M, KHANSAHEB H, et al. Coinfections in patients hospitalized with COVID-19: A descriptive study from the united arab emirates[J]. Infect Drug Resist, 2021,14:2289-2296. DOI:10.2147/IDR.S314029.
[8] PRESTEL C, ANDERSON E, FORSBERG K, et al. Candida auris outbreak in a COVID-19 specialty care unit-Florida, July-August 2020[J]. MMWR Morb Mortal Wkly Rep, 2021,70(2):56-57.
[9] VILLANUEVA-LOZANO H, TREVINO-RANGEL R J, GONZALEZ G M, et al. Outbreak of Candida auris infection in a COVID-19 hospital in Mexico[J]. Clin Microbiol Infect, 2021, 27(5):813-816.
[10] RODRIGUEZ J Y, LE PAPE P, LOPEZ O, et al. Candida auris: A latent threat to critically ill patients with coronavirus disease 2019[J]. Clin Infect Dis, 2021,73(9): e2836-e2837.
[11] ZUO T, ZHAN H, ZHANG F, et al. Alterations in fecal fungal microbiome of patients with COVID-19 during time of hospitalization until discharge[J]. Gastroenterology, 2020,159(4):1302-1310.
[12] CHOWDHARY A, TARAI B, SINGH A, et al. Multidrug-resistant Candida auris infections in critically ill coronavirus disease patients, India, April-July 2020[J]. Emerg Infect Dis, 2020,26(11):2694-2696.
[13] NOBREGA D A J J, BRANDAO I B, FRANCISCO E C, et al. Axillary digital thermometers uplifted a multidrug-susceptible Candida auris outbreak among COVID-19 patients in Brazil[J]. Mycoses, 2021,64(9):1062-1072.
[14] ALLAW F, KARA Z N, IBRAHIM A, et al. First Candida auris outbreak during a COVID-19 pandemic in a tertiary-care center in Lebanon[J]. Pathogens, 2021,10(2):157.
[15] 徐英春, 黄晶晶, 肖盟, 等. 中国耳念珠菌临床感染现状[J]. 协和医学杂志, 2019,10(5):442-445.
[16] WANG X, BING J, ZHENG Q, et al. The first isolate of Candida auris in China: clinical and biological aspects[J]. Emerg Microbes Infect, 2018,7(1):93.
[17] TIAN S, RONG C, NIAN H, et al. First cases and risk factors of super yeast Candida auris infection or colonization from Shenyang, China[J]. Emerg Microbes Infect, 2018,7(1):128.
[18] TANG H J, LAI C C, LAI F J, et al. Emergence of multidrug-resistant Candida auris in Taiwan[J]. Int J Antimicrob Agents, 2019,53(5):705-706.
[19] BING J, WANG S, XU H, et al. A case of Candida auris candidemia in Xiamen, China, and a comparative analysis of clinical isolates in China. Mycology,2021,13(1):68-75.
[20] 宁永忠. 成人耳念珠菌感染诊治防控专家共识[J]. 临床检验杂志, 2020,38(8):564-570.
[21] KORDALEWSKA M, ZHAO Y, LOCKHART S R, et al. Rapid and accurate molecular identification of the emerging multidrug-resistant pathogen Candida auris[J]. J Clin Microbiol, 2017,55(8):2445-2452.
[22] VALLABHANENI S, KALLEN A, TSAY S, et al. Investigation of the first seven reported cases of Candida auris, a globally emerging invasive, multidrug-resistant fungus-united states, May 2013-August 2016[J]. Am J Transplant, 2017,17(1):296-299.
[23] LOCKHART S R, ETIENNE K A, VALLABHANENI S, et al. Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses[J]. Clin Infect Dis, 2017,64(2):134-140.
[24] SHARMA C, KUMAR N, PANDEY R, et al. Whole genome sequencing of emerging multidrug resistant Candida auris isolates in India demonstrates low genetic variation[J]. New Microbes New Infect, 2016,13:77-82.DOI:10.1016/j.nmni.2016.07.003.
[25] 美国疾病控制和预防中心.耳念珠菌. 2020-05-29. https://www.cdc.gov/fungal/candida-auris/c-auris-antifungal.html.
[26] CHEN Y, ZHAO J, HAN L, et al. Emergency of fungemia cases caused by fluconazole-resistant Candida auris in Beijing, China[J]. J Infect, 2018,77(6):561-571.
[27] 邴健. 耳念珠菌耐药机制研究进展[J]. 菌物学报, 2020,39(11):2120-2130.
[28] WRING S, BORROTO-ESODA K, SOLON E, et al. SCY-078, a novel fungicidal agent, demonstrates distribution to tissues associated with fungal infections during mass balance studies with intravenous and oral[(14)C]. SCY-078 in albino and pigmented rats[J]. Antimicrob Agents Chemother, 2019,63(2):e02119-18.
[29] HAMAD A, CHEN Y, KHAN M A, et al. Schiff bases of sulphonamides as a new class of antifungal agent against multidrug-resistant Candida auris[J]. Microbiologyopen, 2021,10(4): e1218.
[30] KOVACS R, NAGY F, TOTH Z, et al. The neosartorya fischeri antifungal protein 2(NFAP2): A new potential weapon against multidrug-resistant Candida auris biofilms[J]. Int J Mol Sci, 2021,22(2):771.

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	MENG Zhongjing, CAO Lulu, LU Jin, LIU Zhongqiu, ZHAN Guanjun. Treatment of postoperative Candida glabrata infection after total knee arthroplasty: a case report [J]. Chinese Journal of Mycology, 2023, 18(4): 331-334.
[2]	. [J]. Chinese Journal of Mycology, 2023, 18(4): 359-363.
[3]	LI Min, ZHAO Jianping, FENG Jiangtao. Analysis of clinical distribution and drug resistance of Candida in a hospital in Inner Mongolia from 2012 to 2021 [J]. Chinese Journal of Mycology, 2023, 18(2): 104-110.
[4]	ZHONG Meizhen, GUO Shaoqing, LI Xiaozhong, ZHU Bo. Clinical analysis of 3 casesof very preterm/extremely preterm infant with bloodstream infection caused by multi-drug resistant Candida haemulonii [J]. Chinese Journal of Mycology, 2023, 18(2): 111-116,134.
[5]	ZHOU Tingting, QIN Renli, XU Qiuhong, LUO Liuchun. Clinical characteristics and risk factors for mortality of 94 patients with Candida bloodstream infection [J]. Chinese Journal of Mycology, 2023, 18(2): 130-134.
[6]	ZHANG Mengxiang, XU Yuewei, YANG Manqin. Clinical dosage regimens of fluconazole evaluated by Monte Carlo simulation in candidal urinary tract infection [J]. Chinese Journal of Mycology, 2023, 18(2): 135-139.
[7]	. [J]. Chinese Journal of Mycology, 2023, 18(2): 163-166,187.
[8]	ZHOU Yihua, DENG Shuwen, ZHANG Lu, ZHANG Hong, ZHAO Rongfen, WANG Yufeng, SUN Yanxia, ZHU Hui. Distribution of pathogenic yeast species of vulvovaginitis and its epidemiological characteristics [J]. Chinese Journal of Mycology, 2023, 18(1): 12-18.
[9]	ZHU Junfeng, ZHOU Ziyang, HU Wangchao, TANG Jianguo. Analysis of clinical characteristics and risk factors of nosocomial fungal urinary tract infection in ICU [J]. Chinese Journal of Mycology, 2022, 17(4): 273-277.
[10]	. [J]. Chinese Journal of Mycology, 2022, 17(2): 173-176.
[11]	. [J]. Chinese Journal of Mycology, 2020, 15(5): 318-320.
[12]	LUO Xia, CHEN Zhen. Effect of multiple vaginal examinations on vaginal microecology during induced labor [J]. Chinese Journal of Mycology, 2020, 15(4): 202-205.
[13]	HUANG Li, GONG Hao, ZHANG Chun-lian, FANG Cai-yun. Investigation of vaginal fungal infections in non-pregnant women [J]. Chinese Journal of Mycology, 2020, 15(4): 213-217.
[14]	ZHANG Wen, LUO Ying, GUO Cheng-jie, XU Ying-chun, XIAO Meng, LEI Cheng-bin, ZHAO Yan, BI Lei. Clinical characteristics and pathogen of patients with candidemia [J]. Chinese Journal of Mycology, 2020, 15(3): 154-160.
[15]	. [J]. Chinese Journal of Mycology, 2020, 15(3): 161-163.